NCT04825054

Brief Summary

Neurally adjusted ventilatory assist (NAVA) is a new mode of mechanical ventilation that delivers ventilatory assist in proportion to neural effort. The investigators hope to compare the hemodynamic and pulmonary effect in children after surgical repair of congenital heart disease with right ventricular hypertrophic ventilated with Pressure control ventilation (PCV), Pressure support ventilation (PSV), and NAVA by a crossover study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 25, 2021

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 1, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

April 1, 2021

Status Verified

March 1, 2021

Enrollment Period

3 days

First QC Date

March 1, 2021

Last Update Submit

March 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiac output index

    Cardiac output index messured by PiCCO and echocariography should be improved when ventilated with NAVA or PSV compared with PCV.

    Within 72 hours after opeartion

Secondary Outcomes (8)

  • Peak inspiratory pressure

    Within 72 hours after opeartion

  • Mean airway pressure

    Within 72 hours after opeartion

  • Arterial partial pressure of oxygen

    Within 72 hours after opeartion

  • Arterial partial pressure of carbon dioxide

    Within 72 hours after opeartion

  • Arterial oxygen saturation

    Within 72 hours after opeartion

  • +3 more secondary outcomes

Study Arms (3)

A 60-min trial ventilated with NAVA

EXPERIMENTAL

Patients underwent surgical repair of right ventricular hypertrophic congenital heart disease. Each patient will undergo three 60-min trials with 30-min wash out during the study period in randomized order. The cardiac output and volume status will be evaluated by a transpulmonary thermodilution device through a pulse contour cardiac output (PiCCO) catheter at the last 10min of each trial. At the mean while an arterial blood gas and echocardiography will perform.

Device: Mechanical ventilation with NAVA mode

A 60-min trial ventilated with PCV

EXPERIMENTAL

Patients underwent surgical repair of right ventricular hypertrophic congenital heart disease. Each patient will undergo three 60-min trials with 30-min wash out during the study period in randomized order. The cardiac output and volume status will be evaluated by a transpulmonary thermodilution device through a pulse contour cardiac output (PiCCO) catheter at the last 10min of each trial. At the mean while an arterial blood gas and echocardiography will perform.

Device: Mechanical ventilation with PCV mode

A 60-min trial ventilated with PSV

EXPERIMENTAL

Patients underwent surgical repair of right ventricular hypertrophic congenital heart disease. Each patient will undergo three 60-min trials with 30-min wash out during the study period in randomized order. The cardiac output and volume status will be evaluated by a transpulmonary thermodilution device through a pulse contour cardiac output (PiCCO) catheter at the last 10min of each trial. At the mean while an arterial blood gas and echocardiography will perform.

Device: Mechanical ventilation with PSV mode

Interventions

To compare the hemodynamic and pulmonary effect in patients after surgical repair with right ventricular hypertrophic ventilated with PCV, PSV and NAVA by a crossover study. Each patient will undergo three 60-min trials during the study period in randomized order. The cardiac output and volume status will be evaluated by a transpulmonary thermodilution device through a pulse contour cardiac output (PiCCO) catheter at the last 10min of each trial. At the mean while an arterial blood gas and echocardiography will perform.

A 60-min trial ventilated with NAVA

To compare the hemodynamic and pulmonary effect in patients after surgical repair with right ventricular hypertrophic ventilated with PCV, PSV and NAVA by a crossover study. Each patient will undergo three 60-min trials during the study period in randomized order. The cardiac output and volume status will be evaluated by a transpulmonary thermodilution device through a pulse contour cardiac output (PiCCO) catheter at the last 10min of each trial. At the mean while an arterial blood gas and echocardiography will perform.

A 60-min trial ventilated with PCV

To compare the hemodynamic and pulmonary effect in patients after surgical repair with right ventricular hypertrophic ventilated with PCV, PSV and NAVA by a crossover study. Each patient will undergo three 60-min trials during the study period in randomized order. The cardiac output and volume status will be evaluated by a transpulmonary thermodilution device through a pulse contour cardiac output (PiCCO) catheter at the last 10min of each trial. At the mean while an arterial blood gas and echocardiography will perform.

A 60-min trial ventilated with PSV

Eligibility Criteria

Age3 Months - 3 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients underwent surgical repair of right ventricular hypertrophic congenital heart disease
  • Obtain informed consent signed by parents

You may not qualify if:

  • Significant residual shunt (more than 2mm), residual obstruction of right ventricular outflow tract (RVOT) or A-V valve insufficiency.
  • Hemodynamic instability (whose inotropic score more than 20);
  • Significant bleed (whose chest drainage more than 5ml/kg/h);
  • Failed to insert the PiCCO catheter
  • Dysfunction and abnormal of esophage;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cardiac intensive care unit, Department of cardiothoracic vascular surgery, Shanghai Children's Medical Center, Medical college of Shanghai Jiaotong University

Shanghai, Shanghai Municipality, 200127, China

RECRUITING

Shanghai Children's Medical Center, Shanghai Jiaotong Universiry School of Medicine

Shanghai, Shanghai Municipality, 200127, China

RECRUITING

Related Publications (1)

  • Gong X, Zhu L, Zhang M, Liu Y, Li C, Xu Z, Zheng J. Utilizing Spontaneous Ventilation Modes in Patients Underwent Corrective Surgery for Right Ventricular Outflow Tract Obstructive Congenital Heart Disease: A Crossover Study. Rev Cardiovasc Med. 2023 May 11;24(5):143. doi: 10.31083/j.rcm2405143. eCollection 2023 May.

MeSH Terms

Conditions

Hypertrophy, Right VentricularHeart Defects, Congenital

Interventions

Respiration, Artificial

Condition Hierarchy (Ancestors)

CardiomegalyHeart DiseasesCardiovascular DiseasesHypertrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsCardiovascular AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Airway ManagementTherapeuticsResuscitationEmergency TreatmentRespiratory Therapy

Study Officials

  • Limin Zhu, M.D.

    Shanghai Children/s Medical Center, Shanghai Jiaotong University School of Medicine

    STUDY DIRECTOR
  • Xiaolei Gong, M.D.

    Shanghai Children/s Medical Center, Shanghai Jiaotong University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Zhuoming Xu, Ph. D & M.D.

    Shanghai Children/s Medical Center, Shanghai Jiaotong University School of Medicine

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: 1. pressure control ventilation 2. pressure support ventilation 3. neurally adjusted ventilatory assist
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Deputy chief physician

Study Record Dates

First Submitted

March 1, 2021

First Posted

April 1, 2021

Study Start

February 25, 2021

Primary Completion

February 28, 2021

Study Completion

December 31, 2021

Last Updated

April 1, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations